82
Participants
Start Date
March 31, 2016
Primary Completion Date
January 5, 2017
Study Completion Date
January 5, 2017
NNZ-2566
Glycyl-L-2-Methylpropyl-L-Glutamic Acid (NNZ-2566) supplied as a lyophilized powder for reconstitution with strawberry flavored solution 0.5% v/v in Water for Injection.
Placebo
Strawberry flavored solution and Water for Injection
Children's Hospital of Philadelphia, Philadelphia
Greenwood Genetic Center, Greenwood
University of Alabama, Birmingham
Vanderbilt University, Nashville
Cincinnati Children's Hospital Medical Center, Cincinnati
Gillette Children's Specialty Healthcare, Saint Paul
Rush University Medical Center, Chicago
Baylor College of Medicine, Houston
Children's Hosptial Colorado, Aurora
University of California, San Diego, San Diego
UCSF Benioff Children's Hospital Oakland, Oakland
Boston Children's Hospital, Boston
Lead Sponsor
rettsyndrome.org
UNKNOWN
Neuren Pharmaceuticals Limited
INDUSTRY